Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Intravitreal Injection of Retinal Progenitor
Intravitreal Injection of Retinal Progenitor Cells Shows Promise in Preclinical Study for Diabetic Retinopathy
Mercury Bio
Mercury Bio Reports Positive Results from Preclinical Study Evaluating Novel Drug Delivery Technology Transporting Protein
Mammoth Biosciences to Present Preclinical Data on MB-111
Mammoth Biosciences to Present Preclinical Data on MB-111 at the European Society of Gene & Cell Therapy 32nd Annual Congress
From Patent to Patient
From Patent to Patient: FDA Policy Ideas to Protect and Speed Medical Innovation
Genmab
Genmab to acquire Merus shares for $8bn
Climb Bio
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN
Mytesi Seeks FDA
Mytesi Seeks FDA Orphan Drug Designation in Breast Cancer Diarrhea
PILA PHARMA
PILA PHARMA enters into agreement with the CRO GUBRA on preclinical trials of XEN-D0501 in obesity
Pharma Tariffs
Pharma Tariffs Back In Spotlight On New Trump Threat
FDA approves Lilly’s Inluriyo
FDA approves Lilly’s Inluriyo to treat advanced breast cancer
Synaffix and Qurient
Synaffix and Qurient enter licensing deal for dual-payload ADC
Biotech Stocks Facing
Biotech Stocks Facing FDA Decision In October 2025
1
2
3
4
5
6
7
8
9
